EQS-Adhoc
LifeWatch AG: LifeWatch AG und BioTelemetry, Inc. erhalten kartellrechtliche Freigabe - Seite 2
Für weitere Informationen: siehe www.lifewatch.com.
E-Mail Alert: Um regelmässig die neusten Informationen zu LifeWatch zu erhalten und Unterlagen anzufordern, registrieren Sie sich bitte unter https://www.lifewatch.com/Investor-Relations/Alert-Service.html.
Zu BioTelemetry
BioTelemetry, Inc., früher als CardioNet bekannt, ist ein führendes Unternehmen im Bereich kabelloser Medizinaltechnologie. Der Fokus liegt auf der Bereitstellung von Gesundheitsdaten zur
Verbesserung der Lebensqualität sowie zur Reduktion der Gesundheitskosten. Das Unternehmen bietet zurzeit Herzüberwachungs-Dienstleistungen an und produziert Geräte mit einem primären Fokus auf die
Herzüberwachung sowie zentralisierte Dienstleistungen für Herzlaboratorien.
Für weitere Informationen: siehe www.biotelinc.com.
Lesen Sie auch
Cautionary Statement Regarding Forward-Looking Statements
This document includes certain forward-looking statements regarding, among other things, statements about BioTelemetry's proposed acquisition of LifeWatch AG, including the timing and success of
the tender offer. These statements may be identified by words such as "expect," "anticipate," "estimate," "intend," "plan," "believe," "promises", "projects," and other words and terms of similar
meaning. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including important factors that could delay, divert, or change any of these
expectations, and could cause actual outcomes and results to differ materially from current expectations. Factors that may materially affect such forward-looking statements include: BioTelemetry's
ability to successfully complete the tender offer for LifeWatch's shares and the failure of any of the conditions to BioTelemetry's tender offer to be satisfied. For further details and a
discussion of these and other risks and uncertainties, please see BioTelemetry's public filings with the Securities and Exchange Commission, including the company's latest periodic reports on Form
10-K and 10-Q respectively, LifeWatch's past press releases, reports and other information posted on LifeWatch's website. Readers are cautioned not to put undue reliance on forward-looking
statements, which reflect only opinions as of the date of this press release. BioTelemetry and LifeWatch do not undertake, and specifically disclaim, any obligation to publicly update or amend any
forward-looking statement, whether as a result of new information, future events, or otherwise.